Get the Weekly Intelligence Brief — top committee picks every Sunday.

INCY vs RDNT

Incyte vs RadNet, Inc. — AI-powered side-by-side comparison
INCY
Incyte
72
Buy
VS
RDNT
RadNet, Inc.
52
Watch
MetricINCYRDNT
AI Score 72 52
Price $121.08 $76.28
P/E Ratio 14.89× -286.45×
ROE 24.9% -1.7%
Revenue Growth YoY
Gross Margin 92.6% 9.7%
Debt / Equity 0.01× 1.99×
Dividend Yield 0.0% 0.0%
RSI (14) 56.2 78.1
Beta 0.769 1.384
Expected Upside

AI Committee View

Current Innellis committee reasoning for INCY versus RDNT.
INCY leads by 20 points.

INCY scores 72/100 (Buy) versus RDNT at 52/100 (Watch).

INCY Committee View
100% agreement
6 analysts

The primary driver is revenue growing 26.9% yoy -- genuine top-line momentum. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • ROE of 29.6% shows genuine earnings power backing the valuation — Value
  • Revenue growing 26.9% YoY -- genuine top-line momentum — Growth
  • EPS growing 80.3% YoY — Growth
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Weekly RSI at 75 -- overbought on the larger timeframe too — Technical
RDNT Committee View
33% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — price-to-book of 5.1x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 5.1x prices in significant intangible value — Value
  • ROE of only -1.4% -- cheap may mean cheap for a reason — Value
  • RSI at 78 is in overbought territory — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
INCY Full Analysis RDNT Full Analysis